FDA issued a Warning Letter to Fresenius Kabi Oncology Ltd on 12/4/2017 as a result of this inspection.
483 Fresenius Kabi Oncology May 2017

483 Fresenius Kabi Oncology May 2017

Larry Hampton FDA, Miguel Martinez FDA$119.00 - Available Now

FDA investigators audited the Fresenius Kabi Oncology - Nadia, India facility and issued inspectional observations (via FDA 483) on 24 May 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 24 May 2017
  • Location: Nadia, India
  • FEI: 3003519498
Add To Cart